Hannah Thurgur (H Thurgur)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 13

Top Topics

Randomized Controlled Trial

Coronavirus Disease

Top Venues

British journal of clinical pharmacology

Archives of suicide research : official journal of the International Academy for Suicide Research

This page only lists publications with an associated author ORCID identifier.

Publications

Michael T Nurmohamed, Hannah Thurgur, Alkyoni Athanasiou-Fragkouli, Anne Katrin Schlag, David John Nutt
Prescribed Medical Cannabis Use Among Older Individuals: Patient Characteristics and Improvements in Well-Being: Findings from T21. Drugs & aging (2024)
Michael T Lynskey, Alkyoni Athanasiou-Fragkouli, Hannah Thurgur, Anne Katrin Schlag, David John Nutt
Medicinal cannabis for treating post-traumatic stress disorder and comorbid depression: real-world evidence. BJPsych open 10 (2) (2024)
Michael T Nurmohamed, Hannah Thurgur, Alkyoni Athanasiou-Fragkouli, Anne Katrin Schlag, David John Nutt
Prescribed Medical Cannabis Use Among Older Individuals: Patient Characteristics and Improvements in Well-Being: Findings from T21. Drugs & aging 41 (6) (2024)
Michael T Nurmohamed, Hannah Thurgur, Alkyoni Athanasiou-Fragkouli, Anne Katrin Schlag, David John Nutt
Prescribed Medical Cannabis Use Among Older Individuals: Patient Characteristics and Improvements in Well-Being: Findings from T21. Drugs & aging 41 (6) (2024)
Michael T Nurmohamed, Hannah Thurgur, Alkyoni Athanasiou-Fragkouli, Anne Katrin Schlag, David John Nutt
Suicidal Ideation in Medicinal Cannabis Patients: A 12-Month Prospective Study. Archives of suicide research : official journal of the International Academy for Suicide Research (2024)
Hannah Thurgur, Michael Lynskey, Anne Katrin Schlag, Carol Croser, David John Nutt, Elizabeth Iveson
Authors' response to letter 'On the use of open-label studies for the evaluation of cannabis-based products for the treatment of long-COVID'. British journal of clinical pharmacology (2024)
Michael T Lynskey, Alkyoni Athanasiou-Fragkouli, Hannah Thurgur, Anne Katrin Schlag, David John Nutt
Medicinal cannabis for treating post-traumatic stress disorder and comorbid depression: real-world evidence. BJPsych open 10 (2) (2024)
Michael T Nurmohamed, Hannah Thurgur, Alkyoni Athanasiou-Fragkouli, Anne Katrin Schlag, David John Nutt
Prescribed Medical Cannabis Use Among Older Individuals: Patient Characteristics and Improvements in Well-Being: Findings from T21. Drugs & aging 41 (6) (2024)
Hannah Thurgur, Michael Lynskey, Anne Katrin Schlag, Carol Croser, David John Nutt, Elizabeth Iveson
Feasibility of a cannabidiol-dominant cannabis-based medicinal product for the treatment of long COVID symptoms: A single-arm open-label feasibility trial. British journal of clinical pharmacology 90 (4) (2024)
Hannah Thurgur, Michael Lynskey, Anne Katrin Schlag, Carol Croser, David John Nutt, Elizabeth Iveson
Feasibility of a cannabidiol-dominant cannabis-based medicinal product for the treatment of long COVID symptoms: A single-arm open-label feasibility trial. British journal of clinical pharmacology 90 (4) (2024)
Michael T Lynskey, Alkyoni Athanasiou-Fragkouli, Hannah Thurgur, Anne Katrin Schlag, David John Nutt
Medicinal cannabis for treating post-traumatic stress disorder and comorbid depression: real-world evidence. BJPsych open 10 (2) (2024)
Hannah Thurgur, Michael Lynskey, Anne Katrin Schlag, Carol Croser, David John Nutt, Elizabeth Iveson
Feasibility of a cannabidiol-dominant cannabis-based medicinal product for the treatment of long COVID symptoms: A single-arm open-label feasibility trial. British journal of clinical pharmacology (2023)
Hannah Thurgur, Michael Lynskey, Anne Katrin Schlag, Carol Croser, David John Nutt, Elizabeth Iveson
Feasibility of a cannabidiol (CBD)-dominant cannabis-based medicinal product (CBMP) for the treatment of Long COVID symptoms: A single arm open-label feasibility trial. British journal of clinical pharmacology (2023)